The Sentences That Create Us draws from the unique insights of over fifty justice-involved contributors and their allies to offer inspiration and resources for creating a literary life in prison. Centering in the philosophy that writers in prison can be as vibrant and capable as writers on the outside, and have much to offer readers everywhere, The Sentences That Create Us aims to propel writers in prison to launch their work into the world beyond the walls, while also embracing and supporting the creative community within the walls. The Sentences That Create Us is a comprehensive resource writers can grow with, beginning with the foundations of creative writing. A roster of impressive contributors including Reginald Dwayne Betts (Felon: Poems), Mitchell S. Jackson (Survival Math), Wilbert Rideau (In the Place of Justice) and Piper Kerman (Orange is the New Black), among many others, address working within and around the severe institutional, emotional, psychological and physical limitations of writing prison through compelling first-person narratives. The book’s authors offer pragmatic advice on editing techniques, pathways to publication, writing routines, launching incarcerated-run prison publications and writing groups, lesson plans from prison educators and next-step resources. Threaded throughout the book is the running theme of addressing lived trauma in writing, and writing’s capacity to support an authentic healing journey centered in accountability and restoration. While written towards people in the justice system, this book can serve anyone seeking hard won lessons and inspiration for their own creative—and human—journey.

Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.